Mitochondrial Switches Regimen for Neurological Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively address the decline in stem cell pools and epigenetic aging, leading to neurological disorders and overall health deterioration, as they either promote asymmetric differentiation or do not consider the nutritional requirements of stem cells.
Innovation Solution
A regimen involving mitochondrial switches to promote symmetric stem cell proliferation, combined with nutritional supplements like alpha-ketoglutarate and fullerenes, to expand stem cell pools, reduce epigenetic age, and remove amyloid beta plaques, thereby protecting the brain and improving neurological function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to address neurological disorders, then treatment is provided, but stem cell pool decline and epigenetic aging are not effectively addressed
Solution Approach 1:
The patent applies multi-functionality by developing a regimen that simultaneously addresses multiple age-related neurological issues: symmetric stem cell proliferation, epigenetic aging reversal, amyloid beta removal, and mitochondrial health improvement. This comprehensive approach allows a single treatment protocol to target multiple pathological processes that conventional single-target therapies cannot address.
Solution Approach 2:
The patent employs parameter changes by modifying key biological parameters through nutritional supplements and interventions: altering stem cell division symmetry (from asymmetric to symmetric), changing epigenetic markers (DNA methylation patterns), modifying mitochondrial function parameters, and adjusting amyloid beta aggregation states. These parameter changes enable the system to transition from a deteriorating state to a restored state.
2Productivity
If asymmetric differentiation is promoted, then specialized cell function is achieved, but stem cell pool depletion occurs
Solution Approach 1:
The patent inverts the conventional asymmetric differentiation process by promoting symmetric division instead. Rather than allowing stem cells to differentiate into specialized functions (asymmetric), the regimen induces symmetric divisions that maintain stem cell identity and expand the pool. This inversion temporarily prioritizes quantity over immediate specialized function, but ultimately supports long-term tissue maintenance through pool expansion.
Solution Approach 2:
The patent applies self-service by enabling stem cells to self-renew through symmetric division in response to nutritional cues. The stem cells autonomously respond to the provided nutrients (alpha-ketoglutarate, fullerenes, mitochondrial substrates) by activating endogenous pathways for symmetric proliferation, without requiring external transplantation or complex external control systems.
3Reliability
If epigenetic modifications are reversed, then youthful gene expression is restored, but the complexity of epigenetic reprogramming increases
Solution Approach 1:
The patent uses nutritional supplements as intermediaries to mediate epigenetic reprogramming. Rather than directly manipulating DNA methylation or histone modification enzymes (which would be complex), the regimen employs small molecules (alpha-ketoglutarate, fullerenes, mitochondrial substrates) that naturally interact with epigenetic enzymes and metabolic pathways. These intermediaries simplify the reprogramming process by working through existing biological pathways rather than requiring artificial gene editing or complex molecular tools.
Data Source
AI summary
Disclosed are methods for the removal of plaques containing amyloid beta, protecting the brain from amyloid beta toxicity, and restoring neurological function by the expansion of neural stem cell pools and improving mitochondrial health.